Nina Reßing
Impact in
-
- Peptidase Inhibition and Analysis
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 7
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 1
- Oncology 4
- Peptidase Inhibition and Analysis 4
- Co-authors
- Finn K. Hansen (9 shared papers)Achim Aigner (2 shared papers)Thomas Büch (1 shared paper)Robert Jenke (1 shared paper)David W. Christianson (4 shared papers)Sanil Bhatia (3 shared papers)Arndt Borkhardt (3 shared papers)J.D. Osko (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (4 papers)Anticancer Research (2 papers)Cancers (1 paper)MedChemComm (1 paper)Archiv der Pharmazie (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Nina Reßing
8 papers receiving 316 citations
Peers
Comparison fields: 5 of 42
- Oncology 126
- Molecular Biology 286
- Organic Chemistry 73
- Pharmaceutical Science 8
- Geriatrics and Gerontology 4
Countries citing papers authored by Nina Reßing
This map shows the geographic impact of Nina Reßing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Reßing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Reßing more than expected).
Fields of papers citing papers by Nina Reßing
This network shows the impact of papers produced by Nina Reßing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Reßing. The network helps show where Nina Reßing may publish in the future.
Co-authors
The 25 scholars most cited alongside Nina Reßing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 140 | |
| 2 | 2018 | 63 | |
| 3 | 2020 | 39 | |
| 4 | 2023 | 33 | |
| 5 | 2022 | 21 | |
| 6 | 2018 | 12 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 2 | |
| 9 | 2025 | 0 |
About Nina Reßing
Nina Reßing is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 9 papers that have together received 316 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), Peptidase Inhibition and Analysis (4 papers), Protein Degradation and Inhibitors (3 papers), Click Chemistry and Applications (2 papers), Ubiquitin and proteasome pathways (2 papers), Malaria Research and Control (1 paper), Epigenetics and DNA Methylation (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Oncology (126 citations), Molecular Biology (286 citations), Organic Chemistry (73 citations), Pharmaceutical Science (8 citations) and Geriatrics and Gerontology (4 citations). Nina Reßing has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Finn K. Hansen, Achim Aigner, Thomas Büch, Robert Jenke, David W. Christianson, Sanil Bhatia, Arndt Borkhardt, J.D. Osko, Julia Hauer and Thomas Kurz. Their work appears in journals such as Journal of Medicinal Chemistry, Anticancer Research, Cancers, MedChemComm and Archiv der Pharmazie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.